Purchases and Sales Made in Q2 2024 in Sana Biotechnology, Inc. (SANA)
This table provides information about the institutional ownership of Sana Biotechnology, Inc. (SANA) during Q2 2024. The information is specifically focused on institutions that hold shares of Sana Biotechnology, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 15, 2024
Q2 2024
|
Susquehanna Fundamental Investments, LLC
Bala Cynwyd, PA |
SELL
|
- |
-91K- 67.73% |
$476K - $950K
|
43.3K
$105K
|
|
|
Aug 09, 2024
Q2 2024
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-112K- 20.2% |
$586K - $1.17M
|
443K
$1.07M
|
|
|
Aug 12, 2024
Q2 2024
|
Citigroup Inc
|
SELL
|
- |
-114K- 24.35% |
$598K - $1.19M
|
355K
$860K
|
|
|
Aug 02, 2024
Q2 2024
|
Td Asset Management Inc
|
SELL
|
- |
-117K- 22.41% |
$611K - $1.22M
|
404K
$979K
|
|
|
Aug 09, 2024
Q2 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-123K- 71.14% |
$643K - $1.28M
|
49.9K
$121K
|
|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
SELL
|
- |
-133K- 35.61% |
$696K - $1.39M
|
241K
$582K
|
|
|
Aug 13, 2024
Q2 2024
|
Crestline Management, LP
Fort Worth, TX |
SELL
|
- |
-140K- 4.16% |
$732K - $1.46M
|
3.23M
$7.81M
|
|
|
Aug 12, 2024
Q2 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-154K- 13.92% |
$805K - $1.61M
|
952K
$2.3M
|
|
|
Aug 13, 2024
Q2 2024
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-156K- 31.36% |
$813K - $1.62M
|
340K
$824K
|
|
|
Aug 09, 2024
Q2 2024
|
Massachusetts Financial Services CO
Boston, MA |
SELL
|
- |
-180K- 75.38% |
$942K - $1.88M
|
58.8K
$142K
|
|
|
Aug 14, 2024
Q2 2024
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-215K- 23.9% |
$1.12M - $2.24M
|
684K
$1.66M
|
|
|
Aug 14, 2024
Q2 2024
|
Verition Fund Management LLC
Greenwich, CT |
SELL
|
- |
-259K- 67.45% |
$1.36M - $2.71M
|
125K
$303K
|
|
|
Aug 14, 2024
Q2 2024
|
Pfm Health Sciences, LP
San Francisco, CA |
SELL
|
- |
-564K- 83.58% |
$2.95M - $5.89M
|
111K
$268K
|
|
|
Aug 14, 2024
Q2 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-577K- 15.63% |
$3.02M - $6.03M
|
3.12M
$7.55M
|
|
|
Aug 14, 2024
Q2 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-682K- 78.42% |
$3.57M - $7.12M
|
188K
$454K
|
|
|
Aug 14, 2024
Q2 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-1.83M- 96.85% |
$9.56M - $19.1M
|
59.4K
$144K
|
|
|
Aug 14, 2024
Q2 2024
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
SELL
|
- |
-3.24M- 67.55% |
$17M - $33.9M
|
1.56M
$3.77M
|